Cantor Fitzgerald maintains its positive outlook on Zoom stock, highlighting the platform's successful integration of artificial intelligence features as a key growth driver.

Cantor Fitzgerald has reiterated its 'overweight' stock rating for both Innoviva and Workday. This indicates a continued positive outlook on the performance of these companies' stocks.

Cantor Fitzgerald has begun offering access to the Kalshi prediction market platform to its institutional clients, expanding their investment opportunities.

Cantor Fitzgerald has reiterated its 'Overweight' rating for Agios Pharma stock and reaffirmed its rating for Analog Devices stock, citing a positive earnings outlook for the latter.

Cantor Fitzgerald has issued a highly bullish forecast, predicting that SK Hynix U.S. shares will double in value within the next 12 months.

UBS has updated its call on United Airlines Holdings Inc (UAL) stock, while Cantor Fitzgerald has updated its call on ON Semiconductor Corp (ON) stock. These updates provide new insights and recommendations for investors regarding these companies.

Truist and other financial firms have raised their price targets for several companies, including Cummins, MasTec, SPX Technologies, Parker-Hannifin, Power Integrations, JFrog, V2X, and KLA. These adjustments reflect updated market outlooks and valuations.

Investment bank Cantor Fitzgerald has indicated that the prolonged 'crypto winter,' a period of declining cryptocurrency prices, may soon be coming to an end.

Cantor Fitzgerald has reiterated its Overweight rating on Gilead Sciences (GILD) following positive results from its HIV trial.

Cantor Fitzgerald has reiterated its 'Neutral' rating for GitLab Inc. (GTLB) stock.

TD Cowen and Cantor Fitzgerald have increased their price targets for Fortinet (FTNT), citing strong growth outlooks in security and AI.

Advanced Energy's stock has seen a significant surge after Cantor Fitzgerald initiated coverage of the company with an 'Overweight' rating, signaling positive investor sentiment.

Cantor Fitzgerald has reiterated its 'Overweight' rating for Intuitive Machines following a major Space Force contract win and maintained its 'Overweight' rating for Summit Therapeutics amidst mixed clinical developments. These reiterations reflect the firm's ongoing assessment of both companies' market positions.

Cantor Fitzgerald has significantly raised its price target for HIVE stock by 50%, indicating a strong positive outlook for the company's shares.

Cantor Fitzgerald has increased its price target for NXP Semiconductors (NXPI), indicating a positive outlook for the company's stock.

Cantor Fitzgerald and Raymond James have increased their price targets for Eli Lilly and Visa, respectively. These adjustments follow the companies' strong first-quarter earnings calls and solid results.

Cantor Fitzgerald has initiated coverage of Shattuck Labs (STTK), providing a new analyst perspective on the company's performance and outlook.

Cantor Fitzgerald has reaffirmed its "Overweight" rating on Riot Platforms (RIOT), citing the global proliferation of artificial intelligence as a key factor in its assessment.

Cantor Fitzgerald has reiterated its Neutral rating for Kinsale (KNSL) stock.

Cantor Fitzgerald has reduced its price target for Keel Infrastructure Corp. (KEEL) from $5 to $3, indicating a revised outlook for the company's stock.

Cantor Fitzgerald has released its assessment of Willis Towers Watson (WTW), providing insights into the company's performance and outlook.

Cantor Fitzgerald has begun coverage on Janus Living and Sonida Senior Living, assigning both companies a 'Buy-equivalent' rating.

Cantor Fitzgerald has reiterated its "Overweight" rating on Hartford Insurance (HIG), indicating a positive outlook for the company's stock.

Cantor Fitzgerald has raised its price target for Bristol Myers (BMY), though it notes a weak catalyst for the first quarter.

The United States reportedly struck military targets on Kharg Island, leading to diminished ceasefire hopes and a decline on Wall Street.

Cantor Fitzgerald has kept a neutral rating on BigBear.ai (BBAI) following what it described as a challenging quarter for the company.

Cantor Fitzgerald has raised its price target for United Therapeutics (UTHR) to $625, suggesting increased confidence in the pharmaceutical company's valuation.

Cantor Fitzgerald has increased its price target for Planet Labs shares from $20 to $40, indicating a more optimistic outlook for the company's stock.

Cantor Fitzgerald has raised its price target for Cullen/Frost Bankers (CFR) but anticipates short-term pressure on bank stocks overall.

Cantor Fitzgerald has reiterated its bullish outlook on Wix.com (WIX).

Several financial firms have updated their price targets for various companies, including B. Riley lowering targets for FS KKR Capital and New Mountain Finance, Lake Street raising targets for Dave and Crexendo, and Cantor Fitzgerald adjusting targets for Belite Bio, BankUnited, Cullen/Frost, and Home BancShares.

Cantor Fitzgerald highlights co-founder support for Remitly Global, Inc. (RELY) following a CEO transition.

Multiple financial institutions have updated their price targets and ratings for various companies, reflecting new outlooks on their performance and market conditions.

Satellogic stands out in the space sector, says Cantor Fitzgerald, because the cost to launch its spacecraft is a fraction of those of some rivals.

Cantor Fitzgerald has significantly increased its holdings by acquiring 3.33 million shares of IREN.

UBS has raised its price target for Cisco Systems, Cantor Fitzgerald has reduced its target for Datadog, and Citi has increased its target for Cloudflare, reflecting varied analyst sentiments on these tech companies.

Analysts discuss potential market downturns for the S&P 500 in 2026 while also highlighting a record silver rally and a promising ETF.

Cantor Fitzgerald maintains its bullish stance on cybersecurity firm CrowdStrike, setting a $250 price target amid strong market demand for security solutions.

DA Davidson has initiated coverage on Everus stock with a 'buy' rating, citing M&A growth potential, while Cantor Fitzgerald has started coverage on Nuvation Bio stock with an 'overweight' rating. These initiations reflect analyst confidence in the future performance of these companies.

Cantor Fitzgerald is reportedly considering offering its institutional clients access to Kalshi's prediction markets. This move would allow more investors to participate in event-based trading.

Cantor Fitzgerald has significantly increased its stake in USA Rare Earth, a move that comes amidst a $1.6 billion commerce deal and a congressional probe.

Cantor Fitzgerald has announced a collaboration with Securitize to facilitate initial public offerings (IPOs) on the blockchain, aiming to leverage distributed ledger technology for capital markets.

Cantor Fitzgerald has increased its price target for Texas Instruments Inc. (TXN), indicating a more optimistic outlook for the semiconductor company's stock.

Cantor Fitzgerald has increased its price target for Marvell Technology (MRVL) stock, suggesting a more optimistic outlook on its future valuation.

Cantor Fitzgerald has increased its price target for ON Semiconductor Corporation (ON), indicating a positive outlook for the company's stock.

Several analysts have raised price targets for various companies, including Insmed (INSM) by Cantor Fitzgerald, Western Digital Corporation (WDC) by JPMorgan, and Lam Research Corporation (LRCX) also by Cantor Fitzgerald.

The US and Europe are discussing access to AI models, while Cantor Fitzgerald CEO Howard Lutnick has reportedly warned Anthropic regarding restrictions on its Mythos AI model.

Applied Materials (AMAT) has seen its price targets raised by both Barclays and Cantor Fitzgerald.

Cantor Fitzgerald has revised its outlook on Harrow (HROW), reducing its price target for the company's stock.

Cantor Fitzgerald has increased its price target for MongoDB (MDB), citing a stable outlook and strong demand driven by the artificial intelligence sector.

HIVE stock experienced a significant jump after Cantor Fitzgerald increased its price target for the company.

Nvidia's stock experienced a rise following reports of its H200 chip sales to China, coupled with Cantor Fitzgerald increasing its price target for the company.

Cantor Fitzgerald has increased its price target for QUALCOMM (QCOM) stock.

Cantor Fitzgerald analysts have indicated that macro risks for Automatic Data Processing (ADP) may be overstated, according to their latest assessment.

Cantor Fitzgerald has increased its price target for NETSTREIT (NTST) stock to $24.

Cantor Fitzgerald has lowered its price target on MARA Holdings (MARA) from $11 to $10, attributing the adjustment to the proliferation of artificial intelligence.

Custom Truck One Source has received an "Overweight" rating from Cantor Fitzgerald, leading its stock to reach a new 52-week high.

Cantor Fitzgerald has downgraded ADMA Biologics Inc. (ADMA) from an 'Overweight' rating to 'Neutral.' This change indicates a revised investment recommendation for the company's stock.

Cantor Fitzgerald and Barclays have issued more positive outlooks on Marvell Technology (MRVL) stock, indicating increased confidence in the company's financial performance.

Cantor Fitzgerald has downgraded its rating for Bitdeer Technologies Group (BTDR), citing concerns over the company's execution.

Cantor Fitzgerald has downgraded ADMA Biologics (ADMA) to a Neutral rating, with reasons provided for the change in their investment stance.

Lam Research (LRCX) presented key highlights during its appearance at the Cantor Fitzgerald Conference.

Cantor Fitzgerald has increased its price target for KLA Corp. (KLAC).

An affiliate of Cantor Fitzgerald has filed a lawsuit against DraftKings and FanDuel, alleging infringement of patents invented by Howard Lutnick.

Cantor Fitzgerald has reduced its price target for Apellis Pharmaceuticals (APLS) from $35 to $31.

Cantor Fitzgerald anticipates a rebound in the analog chip sector, suggesting that companies like Analog Devices and Microchip Technology may continue to outperform in the market.

As Howard Lutnick sold Cantor Fitzgerald to his children, the cryptocurrency company Tether reportedly provided them with a loan.

LifeMD shares surged following reports that Cantor Fitzgerald reiterated its Overweight rating on the company after a strong Q4 earnings report.

Remitly (RELY) received an 'Overweight' rating from Cantor Fitzgerald, driven by strong Q4 performance and better-than-expected 2026 guidance.

Cantor Fitzgerald has adjusted its price target for Universal Health Services, Inc. (UHS) to $229 while maintaining a Neutral rating on the stock.

Cantor Fitzgerald has increased its price target for Innoviva, Inc. (INVA) from $31 to $32, providing the rationale for the adjustment.

Cantor Fitzgerald has raised its price target for Texas Instruments (TXN), foreseeing a balanced earnings outlook for the company.

Cantor Fitzgerald has reportedly doubled down on its investment in a crypto stock, indicating increased confidence or strategic positioning in the cryptocurrency market.

Nvidia shares have gone nowhere this year, but a Cantor Fitzgerald analyst sees next Wednesday’s earnings report as the first of a few notable catalysts.

Cantor Fitzgerald has upgraded DigitalOcean Holdings, Inc. (DOCN) stock from Neutral to Overweight and raised its price target, signaling a positive outlook for the company.

Cantor Fitzgerald remains optimistic about the stock market, citing the ongoing boom in artificial intelligence technology as a key driver for its positive outlook.

Cantor Fitzgerald has reiterated its stock rating for Salesforce, citing the company's AI potential, and initiated coverage of Milestone Pharmaceuticals with an overweight rating. These actions reflect the firm's assessment of both companies' market prospects.

Hedge funds, including Cantor Fitzgerald, are preparing to engage in institutional trading on prediction market platforms such as Kalshi.

Cantor Fitzgerald is betting that SK Hynix stock has the potential to reach $300, indicating a strong bullish outlook for the semiconductor company.

Cantor Fitzgerald has raised its price target for Teradyne, Inc. (TER), reflecting a positive adjustment in its valuation of the company's stock.

Senator Elizabeth Warren is investigating Cantor Fitzgerald's involvement in a $1.6 billion US Rare Earth deal, raising questions about the financial firm's role.

Cantor Fitzgerald has highlighted Remitly Global (RELY) for its long-term growth potential in the digital remittances sector, indicating positive outlook for the company's financial performance.

Cantor Fitzgerald's Bitcoin SPAC is allowing investors to commit less capital as the cryptocurrency market experiences a slide, reflecting adjustments in response to current market conditions.

Cantor Fitzgerald has adjusted its outlook on Tyler Technologies (TYL) stock, lowering its price target. This change reflects a revised assessment of the company's financial prospects or market conditions.

Cantor Fitzgerald has raised its price target for Sandisk Corp. (SNDK), signaling increased confidence in the company's financial prospects.

Multiple financial institutions, including Rosenblatt, Cantor Fitzgerald, Scotiabank, Mizuho, and Loop Capital, have raised their price targets for various companies. These companies include The Walt Disney Company, Applied Materials, Snowflake, Humana, Molina Healthcare, and THOR Industries.

Cantor Fitzgerald has reaffirmed its 'Overweight' rating on Remitly (RELY), following the company's strong growth in money transfers.

Cantor Fitzgerald has reaffirmed its Overweight rating on Visa (V) after the payment processing giant reported stronger-than-expected earnings.

Nvidia's stock has surged to new highs, with analysts raising price targets and anticipating significant market value swings following strong earnings and future product catalysts. The company's shares are experiencing substantial gains driven by investor optimism.

Cantor Fitzgerald has expressed a bullish outlook on Innoviva, Inc. (INVA), citing the company's strong recurring royalty revenue as a key factor. This positive assessment highlights Innoviva's financial stability and potential for growth.

GlobalFoundries received an upgrade from Cantor Fitzgerald ahead of its investor day, where the company also unveiled new packaging solutions. The positive analyst sentiment reflects confidence in its future prospects.

Cantor Fitzgerald has raised its price target for MicroStrategy (MSTR) by $20, indicating increased confidence in the business intelligence firm's stock performance.

Cantor Fitzgerald has lowered its price target on Cipher Digital to $22, while simultaneously highlighting AI infrastructure as an "attractive place to invest." The firm's analysis suggests a strategic focus on the AI sector.

Howard Lutnick, CEO of Cantor Fitzgerald, stated that Nvidia has not yet sold its H200 artificial intelligence chips to China, amid ongoing export restrictions.

Cantor Fitzgerald has lowered its price target for M&T Bank Corporation (MTB) but still sees strong growth drivers intact for the company.

Cantor Fitzgerald has announced a reduction in its price target for IREN Limited, prompting investors to review the stock's outlook.

Robinhood and Coinbase stocks are experiencing a rally, fueled by analyst reports suggesting they are best positioned to capitalize on the potential growth of prediction markets. These markets are projected to expand into a $1 trillion industry.

Cantor Fitzgerald has adjusted CleanSpark, Inc.'s (CLSK) price target downwards, though the firm maintains a bullish stance on the broader AI infrastructure sector.

Cantor Fitzgerald has reduced its price target for pharmaceutical company AbbVie (ABBV), citing a weak catalyst outlook for the sector.

Cantor Fitzgerald has downgraded its rating for Gossamer Bio (GOSS) to Neutral.

Cantor Fitzgerald has reiterated its 'Overweight' rating for Applied Materials (AMAT), signaling continued confidence in the company's stock performance.

Cantor Fitzgerald and Morgan Stanley have maintained their ratings on Rivian (RIVN) following recent new deals.

Cantor Fitzgerald has increased its price target for Centuri Holdings (CTRI) to $37.40.

Cantor Fitzgerald views the current market pullback as a potential opportunity for investors, suggesting a positive outlook amidst recent market fluctuations.

Cantor Fitzgerald has lowered its price target on Oracle (ORCL) to $229, despite strong demand reported across the company's database and SaaS segments.

Morgan Stanley has increased its price target for Nu Holdings Ltd. (NU) to $21.

Cantor Fitzgerald and DA Davidson have lowered their price targets for Okta, Inc. (OKTA) but continue to maintain a bullish outlook on the stock.

Cantor Fitzgerald has reduced its price target for Lucid Group, Inc., citing lower production and forecast expectations.

Cantor Fitzgerald has increased its price target for Acadia Healthcare to $20 from $17, reflecting a more positive assessment of the company's stock.

Cantor Fitzgerald is under fire for alleged tariff trades that never materialized, raising questions about the firm's trading practices.

Vaxcyte (PCVX) is proceeding with a $632.5 million stock offering, following a positive rating from Cantor Fitzgerald.

Cantor Fitzgerald has maintained an Overweight rating on Riot Platforms, Inc. (RIOT), signaling a positive long-term outlook for the company.

Several financial institutions, including Stifel, Scotiabank, and Jefferies, have issued updated price targets and ratings for various companies. These reports reflect analysts' current outlooks on stock performance and investment recommendations.